Skip to main content
Fig. 2 | Acta Neuropathologica Communications

Fig. 2

From: Surfen, a proteoglycan binding agent, reduces inflammation but inhibits remyelination in murine models of Multiple Sclerosis

Fig. 2

Surfen ameliorates EAE. a Clinical scores in mice with EAE, either vehicle treated or surfen treated (dosage and numbers indicated). b Number of days spent with clinical scores above 2.5 in each group. c Changes in body weight in each group. d Changes in body weight in CFA + PTX controls treated with vehicle (CFA - Vehicle) or surfen (CFA - Surfen). Data are shown as mean ± SEM; significant data is marked for surfen versus vehicle, comparing time points (a,c) or grouped data (b); * = P < 0.05

Back to article page

Acta Neuropathologica Communications

ISSN: 2051-5960

Contact us